Vivo Opportunity, LLC's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Mar 28, 2025
- Accession no.
- 0001013762-25-004322
- Filed
- Mar 28, 2025, 7:03 PM ET
- Trade date
- Mar 26-28, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $124.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vivo Opportunity, LLCCIK 0001728970 | 10% Owner |
| Vivo Opportunity Fund Holdings, L.P.CIK 0001930214 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Common Stock | SSaleDisposed | −400,000 | $65.80 | −$26,320,000 | 5,891,851 | Indirect | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −1,100,000 | $67.80 | −$74,580,000 | 4,791,851 | Indirect | |
| Mar 28, 2025 | Common Stock | SSaleDisposed | −333,557 | $70.60 | −$23,549,124.2 | 4,458,294 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.